Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials

Phommasone K., van Leth F., Peto TJ., Landier J., Nguyen T-N., Tripura R., Pongvongsa T., Lwin KM., Kajeechiwa L., Thwin MM., Parker DM., Wiladphaingern J., Nosten S., Proux S., Nguon C., Davoeung C., Rekol H., Adhikari B., Promnarate C., Chotivanich K., Hanboonkunupakarn B., Jittmala P., Cheah PY., Dhorda M., Imwong M., Mukaka M., Peerawaranun P., Pukrittayakamee S., Newton PN., Thwaites GE., Day NPJ., Mayxay M., Hien TT., Nosten FH., Cobelens F., Dondorp AM., White NJ., von Seidlein L.